- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Dying in the City of the Blues: Sickle Cell Anemia and the Politics of Race and Health
Hastings Center Report 32 (4):46 (2002)
Abstract
"Dying in the City of Blues: Sickle Cell Anemia and the Politics of Race and Health" by Keith Wailoo is reviewed.Other Versions
No versions found
My notes
Similar books and articles
Keith Wailoo. Dying in the City of the Blues: Sickle Cell Anemia and the Politics of Race and Health. 352 pp., illus., notes, index. Chapel Hill: University of North Carolina Press, 2001. $34.95 ; $16.95. [REVIEW]Pauline M. H. Mazumdar - 2005 - Isis 96 (3):465-466.
Keith Wailoo;, Stephen Pemberton. The Troubled Dream of Genetic Medicine: Ethnicity and Innovation in Tay‐Sachs, Cystic Fibrosis, and Sickle Cell Disease. x + 249 pp., index. Baltimore: Johns Hopkins University Press, 2006. $21.95. [REVIEW]Michel Morange - 2008 - Isis 99 (1):229-230.
Genetic Marker of Segregation: Sickle Cell Anemia, Thalassemia, and Racial Ideology in American Medical Writing 1920-1950.Keith Wailoo - 1996 - History and Philosophy of the Life Sciences 18 (3):305 - 320.
Laws in Question: Confusion over Sickle Cell Testing.Tabitha M. Powledge - 1972 - Hastings Center Report 2 (6):3-4.
When a Blood Donor Has Sickle Cell Trait:Incidental Findings and Public Health.Lisa M. Lee & Peter Marks - 2014 - Hastings Center Report 44 (4):17-21.
The use of race in medicine as a proxy for genetic differences.Michael Root - 2003 - Philosophy of Science 70 (5):1173-1183.
High-Priced Sickle Cell Gene Therapies Threaten to Exacerbate US Health Disparities and Establish New Pricing Precedents for Molecular Medicine.Frazer A. Tessema, Ameet Sarpatwari, Leah Z. Rand & Aaron S. Kesselheim - 2022 - Journal of Law, Medicine and Ethics 50 (2):380-384.
Red Crescents: Race, Genetics, and Sickle Cell Disease in the Middle East.Elise K. Burton - 2019 - Isis 110 (2):250-269.
Analytics
Added to PP
2013-11-22
Downloads
46 (#504,117)
6 months
6 (#572,300)
2013-11-22
Downloads
46 (#504,117)
6 months
6 (#572,300)
Historical graph of downloads
Citations of this work
Race Based Medicine, Colorblind Disease: How Racism in Medicine Harms Us All.Ruqaiijah Yearby - 2021 - American Journal of Bioethics 21 (2):19-27.
The molecular vista: current perspectives on molecules and life in the twentieth century.Mathias Grote, Lisa Onaga, Angela N. H. Creager, Soraya de Chadarevian, Daniel Liu, Gina Surita & Sarah E. Tracy - 2021 - History and Philosophy of the Life Sciences 43 (1):1-18.
Sickle Cell Disease and the “Difficult Patient” Conundrum.Edward J. Bergman & Nicholas J. Diamond - 2013 - American Journal of Bioethics 13 (4):3 - 10.
The Molecular Basis of Evolution and Disease: A Cold War Alliance.Edna Suárez-Díaz - 2019 - Journal of the History of Biology 52 (2):325-346.
Assessing Latour: The case of the sickle cell body in history.Simon M. Dyson - 2019 - European Journal of Social Theory 22 (2):212-230.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-8d48cdbf4-jdnsr uwo